FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2395084071> ?p ?o ?g. }

• W2395084071 endingPage "84" @default.
• W2395084071 startingPage "775" @default.
• W2395084071 abstract "The plasma kinetics and tissue distribution of ketanserin [+)-3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)- quinazolinedione, R 41 468) were studied in the rat, rabbit and dog. The studies were performed utilizing 3H- and 14C-labelled ketanserin and appropriate techniques to measure levels of radioactivity, unchanged drug and a major metabolite ketanserin-ol in plasma and tissues. Following intravenous administration to male rats and dogs (10 mg/kg), plasma levels could be described by a two-compartment model. The plasma clearance (C1) averaged 3.8 and 19.2 ml/min/kg and the volume of distribution (Vdss) 0.67 and 4.7 l/kg in male rats and in dogs, respectively. Following oral administration (10-40 mg/kg), ketanserin was rapidly and completely absorbed in all species studied. The absolute bioavailability of oral ketanserin was more than 80% in both rats and dogs. Due to the high clearance of the metabolites in rats, ketanserin was the main component of the plasma radioactivity. In dogs, the fraction of the metabolite ketanserin-ol was more pronounced than that of ketanserin. The apparent elimination half-life of ketanserin was 1.5 h in rabbits, 2-5 h in rats and 3-15 in dogs. The pharmacokinetics of ketanserin were dose-related after single and chronic intravenous and oral dosing. Distribution studies in rats after intravenous and oral administration (10 mg/kg) demonstrated an almost immediate equilibrium between plasma and tissues, resulting in slightly higher tissue than plasma concentrations in the well perfused tissues, and similar or slightly lower levels in the remaining tissues. Ketanserin was the main component of tissue radioactivity. The drug crossed the blood-brain barrier only to a slight extent, brain levels of the unchanged drug being similar to the free fraction in plasma. Ketanserin disappeared from tissues with a similar half-life to that in plasma. On repeated dosing, a small fraction of metabolites was more slowly eliminated. The excretion of the urinary and faecal metabolites after repeated dosing was very similar to that after a single dose. Placental transfer of ketanserin in the rat was limited. On average 0.3% of the maternal radioactive dose, preferentially metabolites, was recovered from the combined foetuses. In dogs orally treated with doses of up to 40 mg/kg/d for 12 months, no undue accumulation or retention of ketanserin or ketanserin-ol was found in any tissue. In lactating dogs orally dosed at 10 mg/kg, preferentially metabolites were excreted in the milk. Concentrations of ketanserin and ketanserin-ol in the milk were respectively 2 and 4 times higher than plasma levels." @default.
• W2395084071 created "2016-06-24" @default.
• W2395084071 creator A5002960789 @default.
• W2395084071 creator A5012154837 @default.
• W2395084071 creator A5034777701 @default.
• W2395084071 creator A5034871005 @default.
• W2395084071 creator A5048445676 @default.
• W2395084071 creator A5082902255 @default.
• W2395084071 creator A5087323838 @default.
• W2395084071 date "1988-06-01" @default.
• W2395084071 modified "2023-09-23" @default.
• W2395084071 title "Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog." @default.
• W2395084071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3178917" @default.
• W2395084071 hasPublicationYear "1988" @default.
• W2395084071 type Work @default.
• W2395084071 sameAs 2395084071 @default.
• W2395084071 citedByCount "4" @default.
• W2395084071 countsByYear W23950840712012 @default.
• W2395084071 countsByYear W23950840712022 @default.
• W2395084071 crossrefType "journal-article" @default.
• W2395084071 hasAuthorship W2395084071A5002960789 @default.
• W2395084071 hasAuthorship W2395084071A5012154837 @default.
• W2395084071 hasAuthorship W2395084071A5034777701 @default.
• W2395084071 hasAuthorship W2395084071A5034871005 @default.
• W2395084071 hasAuthorship W2395084071A5048445676 @default.
• W2395084071 hasAuthorship W2395084071A5082902255 @default.
• W2395084071 hasAuthorship W2395084071A5087323838 @default.
• W2395084071 hasConcept C110121322 @default.
• W2395084071 hasConcept C112705442 @default.
• W2395084071 hasConcept C121332964 @default.
• W2395084071 hasConcept C125287762 @default.
• W2395084071 hasConcept C126322002 @default.
• W2395084071 hasConcept C134018914 @default.
• W2395084071 hasConcept C134306372 @default.
• W2395084071 hasConcept C139254425 @default.
• W2395084071 hasConcept C170493617 @default.
• W2395084071 hasConcept C181389837 @default.
• W2395084071 hasConcept C185592680 @default.
• W2395084071 hasConcept C24890656 @default.
• W2395084071 hasConcept C2775864247 @default.
• W2395084071 hasConcept C2776575606 @default.
• W2395084071 hasConcept C2776894844 @default.
• W2395084071 hasConcept C2777056448 @default.
• W2395084071 hasConcept C2777477808 @default.
• W2395084071 hasConcept C2777785214 @default.
• W2395084071 hasConcept C33923547 @default.
• W2395084071 hasConcept C53910766 @default.
• W2395084071 hasConcept C71924100 @default.
• W2395084071 hasConcept C98274493 @default.
• W2395084071 hasConceptScore W2395084071C110121322 @default.
• W2395084071 hasConceptScore W2395084071C112705442 @default.
• W2395084071 hasConceptScore W2395084071C121332964 @default.
• W2395084071 hasConceptScore W2395084071C125287762 @default.
• W2395084071 hasConceptScore W2395084071C126322002 @default.
• W2395084071 hasConceptScore W2395084071C134018914 @default.
• W2395084071 hasConceptScore W2395084071C134306372 @default.
• W2395084071 hasConceptScore W2395084071C139254425 @default.
• W2395084071 hasConceptScore W2395084071C170493617 @default.
• W2395084071 hasConceptScore W2395084071C181389837 @default.
• W2395084071 hasConceptScore W2395084071C185592680 @default.
• W2395084071 hasConceptScore W2395084071C24890656 @default.
• W2395084071 hasConceptScore W2395084071C2775864247 @default.
• W2395084071 hasConceptScore W2395084071C2776575606 @default.
• W2395084071 hasConceptScore W2395084071C2776894844 @default.
• W2395084071 hasConceptScore W2395084071C2777056448 @default.
• W2395084071 hasConceptScore W2395084071C2777477808 @default.
• W2395084071 hasConceptScore W2395084071C2777785214 @default.
• W2395084071 hasConceptScore W2395084071C33923547 @default.
• W2395084071 hasConceptScore W2395084071C53910766 @default.
• W2395084071 hasConceptScore W2395084071C71924100 @default.
• W2395084071 hasConceptScore W2395084071C98274493 @default.
• W2395084071 hasIssue "6" @default.
• W2395084071 hasLocation W23950840711 @default.
• W2395084071 hasOpenAccess W2395084071 @default.
• W2395084071 hasPrimaryLocation W23950840711 @default.
• W2395084071 hasRelatedWork W1906219835 @default.
• W2395084071 hasRelatedWork W2020343058 @default.
• W2395084071 hasRelatedWork W2021551397 @default.
• W2395084071 hasRelatedWork W2093230880 @default.
• W2395084071 hasRelatedWork W2148177218 @default.
• W2395084071 hasRelatedWork W2155832430 @default.
• W2395084071 hasRelatedWork W2160414036 @default.
• W2395084071 hasRelatedWork W2317627837 @default.
• W2395084071 hasRelatedWork W2463077557 @default.
• W2395084071 hasRelatedWork W3120625362 @default.
• W2395084071 hasVolume "38" @default.
• W2395084071 isParatext "false" @default.
• W2395084071 isRetracted "false" @default.
• W2395084071 magId "2395084071" @default.
• W2395084071 workType "article" @default.